Tanja Obradovic, Oncology Medical Strategy Advisor at Mercurial AI and Consultant of Oncology Drug Development at Arc Nouvel Clinical Development Consulting, shared a post on LinkedIn:
“Glad to present at incoming International Conference on Cancer Science and Research on ‘Development of Novel Cancer Immunotherapies-Medical Strategy Toward Success’.
Looking forward to share critical elements of clinical trial and pipeline design with optimal decision making from early-to-late stage of development with oncology community.
Expecting productive exchange so tune in from Nov 17-19th in Singapore or online.”
More posts featuring Tanja Obradovic.